InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: None

Thursday, 01/17/2008 9:29:02 PM

Thursday, January 17, 2008 9:29:02 PM

Post# of 785
Nsomniyak challenge:

This nsomniyak challenge is going to be reflective of my stock picking strategy for this contest, haphazard and not well thought out.

ADGO.ob: I don't own it because I don't trust their management and their history of awarding penny options to themselves; but they have been consistently profitable....and they have been showing some respectable growth. I picked it because I know they plan on doing a 4:1 split...and I wanted to make SSK do some extra work on top of all the other stuff he does to keep this contest going.

ALRG.ob: I don't own it; but didn't think anyone else here did either, so I picked it to be unique. They are cheap with a market cap of $12M and $4M in cash, consistently profitable, and last quarter's results seam like they might be on the cusp of some growth....so I thought it was worth a shot for this contest.

AYSI: I do own it. I picked it for this contest because everyone else is doing it.

CNEH: I don't own it because I don't trust it; but everyone else is doing it.

OISI: I do own some. Their trailing numbers look great, their proposed acquisition of Medivision adds some uncertainty. Their proposed acquisition of AcerMed adds some potential spunk to this pick, as the investment community is bidding up plays on the paperless doctor's office. But there's a lot of uncertainty to, so we'll have to see how all this pans out.

TMED.ob: I own it....a lot of it. They've been working on developing a laser fiber for BPH treatment for HoLAP lasers that BSX and Lumenis sell (Lumenis manufactures). They collect a 7.5% royalty on the fibers BSX currently sells; but their new fiber is being designed to meet higher performance standards (faster ablation and lower failure rates); which should make HoLAP lasers more competitive for BPH procedures overall.

The company has missed its own time frame twice now and those delays have caused investors to hammer this stock down to it’s current price range. But in the recent annual report, the company said they think they've got the technical issues figured out....and I tend to trust them. It's a bit of a lottery ticket; but I think the odds are pretty good despite the market's impatience. It's been less than two years since they announced this initiative, which isn't very much time at all in the development of medical devices.

Well, good luck everybody!

"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.